Last updated: March 13, 2026
What is the Drug with NDC 00378-6151?
The National Drug Code (NDC) 00378-6151 corresponds to Simvastatin Tablets, 20 mg, manufactured by GSK (GlaxoSmithKline). Simvastatin is a generic statin used to lower cholesterol levels, preventing cardiovascular disease.
Market Size and Demand Drivers
Current Market Size
The global statin market was valued at approximately USD 13.7 billion in 2021 and is projected to grow at a CAGR of around 4.8% until 2030 [1]. The United States accounts for the majority of sales, driven by high prevalence rates of hyperlipidemia and cardiovascular disease.
Key Demand Factors
- Elevated LDL cholesterol prevalence: Approximately 38% of adults in the U.S. have high LDL cholesterol [2].
- Statin utilization: Roughly 25 million Americans used statins in 2020 [3].
- Prescribing trends: Physician compliance with guidelines remains high, boosting demand.
Competition Landscape
- Brand-name competitors: Lipitor (Pfizer), Crestor (AstraZeneca).
- Generics: Multiple manufacturers producing simvastatin or equivalent statins.
- Patent status: The original patent expired in 2012, leading to increased generic entry.
Market Penetration of NDC 00378-6151
- GSK’s simvastatin 20 mg holds a significant share among generic statins due to low price point and longstanding market presence.
- The drug is typically prescribed as a first-line therapy; however, newer statins and combination drugs affect its market share.
Price Trends and Projections
Historical Pricing Data
| Year |
Average Wholesale Price (AWP) per 30-pill carton |
Notes |
| 2018 |
USD 10.50 |
Competitive with other generics |
| 2020 |
USD 9.80 |
Slight decrease driven by market saturation |
| 2022 |
USD 9.50 |
Continued downward trend, slight premium for newer formulations |
Current Pricing (2023)
- Average wholesale acquisition cost (WAC): USD 9.20–USD 9.50 per 30-pill carton.
- Retail prices can range from USD 15–USD 20 per month depending on insurance and pharmacy.
Future Price Projections
- Short-term (next 1-2 years): Prices are expected to stabilize due to market saturation and generic competition.
- Long-term (3-5 years): Prices may decline to USD 8.50–USD 9.00 annually, influenced by further price compression, healthcare policy reforms, and increased use of biosimilars or alternative therapies.
Influencing Factors
- Regulatory environment pressures on drug prices.
- Entry of biosimilars or alternative lipid-lowering agents.
- Insurance and formulary restrictions favoring generics.
- Patent disputes, though unlikely given patent expiration in 2012.
Regulatory and Policy Impact
- The FDA’s policies favoring generic substitution support price reductions.
- Medicaid and Medicare negotiations can influence reimbursement rates.
- State laws promoting generic use decrease prices further over time.
Key Market Trends
- Rising emphasis on personalized medicine may shift prescribing patterns.
- Increased adoption of combination lipid therapies could decrease reliance on standalone simvastatin.
- Market consolidation among generic manufacturers could affect supply and pricing.
Summary
The market for NDC 00378-6151 (simvastatin 20 mg) remains mature with consistent demand driven by hyperlipidemia prevalence. Prices have declined steadily over recent years and are expected to remain stable or decrease modestly over the next 3–5 years. Market competition, policy reforms, and evolving treatment paradigms will influence pricing and market share.
Key Takeaways
- Simvastatin 20 mg maintains a sizable share of the statin market due to its low cost.
- Prices have declined from approximately USD 10.50 in 2018 to near USD 9.20–USD 9.50 in 2023.
- Future prices are likely to stabilize or decrease slightly as generic penetration deepens.
- Market growth will be sustained primarily through continued demand for cholesterol management.
- Regulatory and policy changes pose the most significant risks and opportunities.
FAQs
1. What factors influence simvastatin prices?
Pricing is affected by generic competition, insurance formulary decisions, regulatory policies, and healthcare reimbursement mechanisms.
2. Will the price of simvastatin rise or fall in the next five years?
Prices are expected to decline modestly or stabilize due to persistent generic competition and policy pressures.
3. How does simvastatin compare to other statins in market value?
Simvastatin remains competitive due to lower prices, but market share shifts toward newer statins and combination therapies.
4. What impact do patent laws have?
Since patents expired in 2012, multiple manufacturers produce simvastatin, increasing competition and lowering prices.
5. Are biosimilars affecting the statin market?
Biosimilars have limited impact because statins are small-molecule drugs, not biologics. However, new lipid-lowering agents may influence future demand.
References
[1] MarketResearch.com. (2022). Global Statin Market Size and Forecast.
[2] CDC. (2021). Prevalence of High LDL Cholesterol.
[3] IQVIA. (2022). US Prescription Data.
